NO20074254L - Krystallinsk og amorf 4-cyano-N[(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioksin-5-yl)-piperazin-1-yl]-propyl)-N-pyridin-2-yl-benzamid-hydroklorid - Google Patents
Krystallinsk og amorf 4-cyano-N[(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioksin-5-yl)-piperazin-1-yl]-propyl)-N-pyridin-2-yl-benzamid-hydrokloridInfo
- Publication number
- NO20074254L NO20074254L NO20074254A NO20074254A NO20074254L NO 20074254 L NO20074254 L NO 20074254L NO 20074254 A NO20074254 A NO 20074254A NO 20074254 A NO20074254 A NO 20074254A NO 20074254 L NO20074254 L NO 20074254L
- Authority
- NO
- Norway
- Prior art keywords
- dioxin
- piperazin
- benzo
- dihydro
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65757505P | 2005-03-01 | 2005-03-01 | |
| PCT/US2006/006802 WO2006093853A1 (en) | 2005-03-01 | 2006-02-27 | Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074254L true NO20074254L (no) | 2007-09-24 |
Family
ID=36659970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074254A NO20074254L (no) | 2005-03-01 | 2007-08-21 | Krystallinsk og amorf 4-cyano-N[(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioksin-5-yl)-piperazin-1-yl]-propyl)-N-pyridin-2-yl-benzamid-hydroklorid |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20070027162A1 (pt) |
| EP (1) | EP1853593A1 (pt) |
| JP (1) | JP2008531694A (pt) |
| KR (1) | KR20070112797A (pt) |
| CN (1) | CN101137648A (pt) |
| AR (1) | AR053152A1 (pt) |
| AU (1) | AU2006218845A1 (pt) |
| BR (1) | BRPI0609370A2 (pt) |
| CA (1) | CA2599588A1 (pt) |
| CR (1) | CR9319A (pt) |
| GT (1) | GT200600098A (pt) |
| IL (1) | IL185267A0 (pt) |
| MX (1) | MX2007010524A (pt) |
| NI (1) | NI200700217A (pt) |
| NO (1) | NO20074254L (pt) |
| PE (1) | PE20061344A1 (pt) |
| RU (1) | RU2007131044A (pt) |
| TW (1) | TW200700413A (pt) |
| WO (1) | WO2006093853A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200800198A (en) * | 2005-09-09 | 2008-01-01 | Wyeth Corp | Pharmaceutical dosage forms and compositions |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
| GB9125900D0 (en) * | 1991-12-05 | 1992-02-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
| US5568992A (en) * | 1995-05-19 | 1996-10-29 | Caterpillar Paving Products Inc. | Screed control system for an asphalt paver and method of use |
| US5756532A (en) * | 1995-11-06 | 1998-05-26 | American Home Products Corporation | Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives |
| US5776969A (en) * | 1997-02-27 | 1998-07-07 | Eli Lilly And Company | Treatment of sleep disorders |
| US6287839B1 (en) * | 1997-11-19 | 2001-09-11 | Genencor International, Inc. | Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
| US6127062A (en) * | 1998-03-24 | 2000-10-03 | Duracell Inc | End cap seal assembly for an electrochemical cell |
| AU758807B2 (en) * | 1998-09-10 | 2003-03-27 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxine carboxamide and ketone derivatives as 5-HT4 receptor antagonists |
| IT1318394B1 (it) * | 2000-03-17 | 2003-08-25 | Enichem Spa | Processo per la preparazione di 1-esene. |
| US6469007B2 (en) * | 2000-11-28 | 2002-10-22 | Wyeth | Serotonergic agents |
| US7091349B2 (en) * | 2002-03-12 | 2006-08-15 | Wyeth | Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| CA2477892C (en) * | 2002-03-12 | 2010-11-23 | Gregg Brian Feigelson | Process for synthesizing chiral n-aryl piperazines |
| KR20040091720A (ko) * | 2002-03-12 | 2004-10-28 | 와이어쓰 | Ｎ1-(2'-피리딜)-1,2-프로판디아민 설팜산의 제조방법 및생물학적 활성 피페라진 합성시의 이의 용도 |
| US20050215561A1 (en) * | 2004-03-19 | 2005-09-29 | Krishnendu Ghosh | Pharmaceutical dosage forms and compositions |
| US20050209245A1 (en) * | 2004-03-19 | 2005-09-22 | Wyeth | Process for preparing N-aryl-piperazine derivatives |
| TWI257220B (en) * | 2005-03-25 | 2006-06-21 | Ind Tech Res Inst | Cross-layer rate adaptation mechanism for WLAN |
-
2006
- 2006-02-27 CN CNA2006800068775A patent/CN101137648A/zh active Pending
- 2006-02-27 EP EP06736178A patent/EP1853593A1/en not_active Withdrawn
- 2006-02-27 MX MX2007010524A patent/MX2007010524A/es unknown
- 2006-02-27 RU RU2007131044/04A patent/RU2007131044A/ru not_active Application Discontinuation
- 2006-02-27 JP JP2007558092A patent/JP2008531694A/ja not_active Withdrawn
- 2006-02-27 US US11/364,902 patent/US20070027162A1/en not_active Abandoned
- 2006-02-27 CA CA002599588A patent/CA2599588A1/en not_active Abandoned
- 2006-02-27 AU AU2006218845A patent/AU2006218845A1/en not_active Abandoned
- 2006-02-27 KR KR1020077021157A patent/KR20070112797A/ko not_active Withdrawn
- 2006-02-27 BR BRPI0609370-1A patent/BRPI0609370A2/pt not_active Application Discontinuation
- 2006-02-27 TW TW095106572A patent/TW200700413A/zh unknown
- 2006-02-27 WO PCT/US2006/006802 patent/WO2006093853A1/en not_active Ceased
- 2006-03-01 AR ARP060100776A patent/AR053152A1/es not_active Application Discontinuation
- 2006-03-01 GT GT200600098A patent/GT200600098A/es unknown
- 2006-03-01 PE PE2006000236A patent/PE20061344A1/es not_active Application Discontinuation
-
2007
- 2007-08-14 IL IL185267A patent/IL185267A0/en unknown
- 2007-08-16 CR CR9319A patent/CR9319A/es not_active Application Discontinuation
- 2007-08-21 NO NO20074254A patent/NO20074254L/no not_active Application Discontinuation
- 2007-08-21 NI NI200700217A patent/NI200700217A/es unknown
-
2009
- 2009-02-03 US US12/365,156 patent/US20090192311A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007010524A (es) | 2008-01-16 |
| CA2599588A1 (en) | 2006-09-08 |
| IL185267A0 (en) | 2008-02-09 |
| TW200700413A (en) | 2007-01-01 |
| AR053152A1 (es) | 2007-04-25 |
| CN101137648A (zh) | 2008-03-05 |
| US20090192311A1 (en) | 2009-07-30 |
| AU2006218845A1 (en) | 2006-09-08 |
| BRPI0609370A2 (pt) | 2010-03-30 |
| WO2006093853A1 (en) | 2006-09-08 |
| CR9319A (es) | 2008-01-21 |
| JP2008531694A (ja) | 2008-08-14 |
| US20070027162A1 (en) | 2007-02-01 |
| GT200600098A (es) | 2006-11-09 |
| EP1853593A1 (en) | 2007-11-14 |
| KR20070112797A (ko) | 2007-11-27 |
| PE20061344A1 (es) | 2007-01-03 |
| NI200700217A (es) | 2008-07-24 |
| RU2007131044A (ru) | 2009-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006013493D1 (de) | Oxadiazolylpyrazolopyrimidine als mglur2-antagonisten | |
| DE602006007556D1 (de) | Heteroarylsulfonylstilbene als 5-ht2a-antagonisten | |
| NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
| DK1716152T3 (da) | Kondenserade heterocykliske forbindelser og deres anvendelse som metabotrope receptorantagonister til behandling af gastrointentinde lidelser | |
| ATE393147T1 (de) | Kondensierte cycloheptan- und kondensierte azacycloheptan-derivate und ihre verwendung als integrin-rezeptor-antagonisten | |
| DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| NO20082909L (no) | Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene | |
| EA200700367A1 (ru) | Новые производные 4-бензилиденпиперидина | |
| MX2008001606A (es) | Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico. | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| MY153719A (en) | Prokineticin 1 receptor antagonists | |
| TW200716566A (en) | Prokineticin 2 receptor antagonists | |
| TR201907381T4 (tr) | Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti. | |
| ATE409179T1 (de) | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten | |
| ATE429421T1 (de) | Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten | |
| PA8626501A1 (es) | Nuevos derivados de bencil(ideno)-lactamas | |
| NO20074254L (no) | Krystallinsk og amorf 4-cyano-N[(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioksin-5-yl)-piperazin-1-yl]-propyl)-N-pyridin-2-yl-benzamid-hydroklorid | |
| DE602005027870D1 (de) | Cgrp-rezeptorantagonisten | |
| WO2005092307A3 (en) | Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists | |
| DE602006020864D1 (de) | 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten | |
| DE602006020450D1 (de) | Ykinin-rezeptorantagonisten | |
| ATE452130T1 (de) | 1-(hetero)aryl-3-aminopyrrolidinderivate zur verwendung als antagonisten des mglur3-rezeptors | |
| PT1893589E (pt) | Derivados substituídos de n-benzo[d]isoxazol-3-il-amina como inibidores de recetores mglur5, recetores de serotonina-(5-ht) e recetores de noradrenalina e sua utilização na produção de medicamentos | |
| NO20081100L (no) | Farmasoytiske doseringsformer og sammensetninger | |
| ATE450503T1 (de) | Pyrrolidinderivate als histamin-h3- rezeptorantagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |